Mnemo Therapeutics Employee Directory
Biotechnology ResearchÎle-de-France, France2-10 Employees
Mnemo Therapeutics is a Paris-based biotechnology company advancing cancer immunotherapies by strengthening the body's ability to detect and eradicate malignant cells. It aims to overcome the scarcity of actionable cancer-specific targets by combining computational and experimental workflows to identify novel tumour-specific targets, referred to as E-antigens, derived from the unexploited dark genome, and to develop multiple therapeutic modalities against them. The company is pursuing several discovery campaigns for E-antigens and intends to build a proprietary portfolio in collaboration with its founding partners. In November 2023, Mnemo announced a preclinical study indicating that CAR T cell memory differentiation and persistence can be enhanced by inactivating SUV39H1, an enzyme that epigenetically regulates memory-associated genes. Mnemo is based in Paris, Île-de-France, and launched in the summer of 2021.
1-888-653-2347 
support@leadiq.com 
